5 july 2019 , Tokyo. In Speaking with an official show director of Reed Exhibition , An official summarised an event as...
5 July 2019 , Tokyo . Interphex Japan concludes in Tokyo 45,000 appx Visitors from around the world including all conc...
04 July 2019 , Tokyo . The reception was held as a networking event that is greatly appreciated by attendees for gainin...
INTERPHEX JAPAN is Japan's largest and Asia's leading exhibition for pharmaceutical manufacturing and packaging technolo...
Seventh Sense Biosystems, Inc. (7SBio), makers of TAP™, the world's first push-button blood collection device, and...
Century Therapeutics, which was created by Versant Ventures as part of the firm’s core strategy to launch innovati...
Takeda has announced the completion of its sale of its Xiidra (lifitegrast ophthalmic solution) 5% product to Novartis f...
Japan headquartered PHC Holdings Corporation has announced the completion of its acquisition of Anatomical Pathology bus...
PeptiDream Inc., a public Kanagawa-based biopharmaceutical company, on 27 June 2019, announced a new Peptide Drug Conjug...
Japanese company Takeda Pharmaceutical has announced the addition of five partners to its Global CSR programme for 2019,...
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has annou...
Daiichi Sankyo Company, Limited and GE Healthcare have agreed that, Daiichi Sankyo will return the exclusive development...
US headquartered Gilead Sciences and Japan based Carna Biosciences has announced that the companies have entered in...
Japanese research-driven pharmaceutical company Shionogi & Co., Ltd., on 24 June 2019, announces that the Company ha...
Ricoh Company, Ltd., (Tokyo, Japan) has announced it has entered into a strategic business partnership with Elixirgen Sc...
Japan headquartered Toray has announced that a small size of TORAYMYXINTM (PMX-05R) had obtained EC certificate and is l...
Myriad Genetic Laboratories, a wholly-owned subsidiary of Myriad Genetics has announced the Japanese Ministry...
Eisai, a leading global research and development-based pharmaceutical company headquartered in Japan has announced ...
Ricoh Company has announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc. to deve...
Roche has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrec...
Daiichi Sankyo Company has announced that the Ministry of Health, Labor and Welfare (MHLW) of Japan has approved VANFLYT...
Catalys Pacific, a new venture capital firm in Japan built by a global team seasoned in life sciences investin...
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has ...
Japan headquartered Terumo Corporation, a leading global medical device manufacturer has announced that it has secured e...
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies has announced it has licensed a ...
Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharm...
Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their mult...
Hamamatsu Photonics K.K. has developed a novel 3D fluorescence scanning method called “Zyncscan™” that...
Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative...
Japan headquartered FUJIFILM Corporation has announced an initial $10M USD investment to establish a...
Takeda Pharmaceutical Company Limited has announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with...
Gavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology Ltd. have signed a memorandum of understanding on ...
Otsuka Chemical Co., Ltd has announced its acquisition on cefixime business from Astellas Pharma, Inc. on 5 June 2019,...
PeptiDream Inc., a public Kanagawa-based biopharmaceutical company, on 5 June 2019, announced a strategic partnership wi...
LPIXEL Inc., a leader in image analysis and processing technology in life science and medical research has announced the...
Takeda Pharmaceutical have became the first private sector company to announce a financial commitment to the Global Fund...
Thermo Fisher Scientific has announced that its Oncomine Dx Target Test CDx System has received reimbursement coverage f...
The CureApp nicotine-dependent treatment app is clinically proved as a higher rate of sustained smoking cessation (CAR) ...
Scientists successfully bioengineered human liver organoids that faithfully mimic key features of fatal liver disease in...
Beam Therapeutics and Bio Palette have announced an exclusive cross-license agreement around each companies’ base ...
PENTAX Medical, a leading provider of endo-imaging solutions, will soon celebrate the 100th anniversary of the foundatio...
Japanese multinational conglomerate company Hitachi has signed a contract with Himed Hospital Management (Xuzhou) C...
Japanese firm Chugai Pharmaceutical Co., Ltd. has announced the decision to construct a core research laboratory, C...
Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terahertz radia...
Japan headquartered Menicon Co. has announced the launch of the Menicon Bloom Myopia Control Management System...
Japan based B dot Medical Inc. has announced that the company has initiated the development of an ultra-compact pro...
Chugai Pharmaceutical has announced that it has obtained regulatory approval for the humanized anti-human IL-6 receptor ...
Elekta (EKTA-B.ST) has announced that its Elekta Unity magnetic resonance radiation therapy system has been approved for...
Eisai Inc., the U.S. pharmaceutical subsidiary of Japan headquartered Eisai Co., Ltd., has announced the immediate appoi...
Takeda Pharmaceutical and Frazier Healthcare Partners have announced a collaboration to launch Phathom Pharmaceuticals, ...
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...
Japanese pharma company Daiichi Sankyo has announced that the Company has been unable to fulfill its obligation to build...
Eisai Co., Ltd. announced that presentations on a series of abstracts highlighting updates regarding its in-house discov...
Teijin Limited has announced that it has signed a research and development agreement with the Japan Agency for Medical R...
Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for rev...
Daiichi Sankyo has announced the launch in Japan of MINNEBRO® Tablets 1.25 mg, 2.5 mg and 5 mg (generic name: e...
Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mb...
Japan headquartered Takeda Pharma has entered into an agreement to sell TachoSil®, a surgical patch designed to achi...
Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the asset...
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...
Promethera Biosciences, a global innovator in cell-based medicines and liver diseases has announced the closing of a &eu...
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...
Eisai Co., Ltd. and the UK Dementia Research Institute (UK DRI) announced the launch of a joint post-doctoral programme ...
US based Skyhawk Therapeutics, Inc. has announced a strategic collaboration with Japan headquartered Takeda Pharmaceutic...
Takeda has announced the opening of a new research facility in San Diego, California. Extending Takeda’s 14-year p...
Global biopharmaceutical company Takeda announced Andrey Potapov as its Area Head for India, CIS (the Commonwealth of In...
Researchers at Okayama University in Japan have reported in the journal Sensors and Actuators B: Chemical that terahertz...
Santen and Glaukos have announced that Santen’s U.S. subsidiary, Santen Inc., has entered into a multi-year agreem...
Zymeworks Inc. a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, and Daiichi Sankyo...
Daiichi Sankyo Company LTD. (Daiichi Sankyo), dedicated to the creation and supply of innovative pharmaceutical products...
Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the pre...
Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, announced that it has ent...
LifeArc, one of the UK’s leading medical research charities, has signed a deal to license an ion channel drug disc...
Eisai Co has been selected by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE)...
ACTmed, a joint venture between Canon Medical Systems Corporation and ACT Genomics, has established an analysis laborato...
Nagasaki University and NEC Corporation have established a program on global health & biometric authentication with ...
Investigations of 'quantum dots' for looking deeply into body tissues are rapidly evolving, but more work is required to...
FUJIFILM and Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University (Professor Toyohiro Hirai...
Permobil, a global leader in advanced rehabilitation technology, has updated its successful modular front wheel dri...
Daiichi Sankyo has announced the launch of Tarlige® Tablets 2.5 mg, 5 mg, 10 mg, 15 mg (generic name: mirogabal...
Shionogi, Japanese major research-driven pharmaceutical company dedicated to bringing benefits to patients has anno...
HitGen has announced that HitGen Inc. and Kaken Pharmaceutical have entered into a license agreement to develop a n...
EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for the treatment of genetic disorders ...
Based on its exclusive license related to photoimmunotherapy, Rakuten Medical Inc., which is developing a cancer therapy...
Ajinomoto Bio-Pharma, a leading provider of biopharmaceutical contract development and manufacturing services has a...
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...
Clinigen K.K. and GC Pharma have recently announced an exclusive licensing agreement in Japan to commercialize...
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has acqui...
Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...
Chugai Pharmaceutical Co., Ltd., Tokyo and Fuji Chemical Industries Co., Ltd., Toyama announced that two companies ...
Hitachi, Ltd. has announced that the radiation therapy started on April 1, 2019 at Nagamori Memorial Center of Innovativ...
Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, T...
StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...
Daiichi Sankyo Company, Limited has entered into a global development and commercialization agreement with AstraZeneca f...
CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes....
Gilead Sciences, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Bikta...
The Global Health Innovative Technology (GHIT) Fund has announced a total of 2.86 billion yen to support 10 partnerships...
Global biotherapeutics leader CSL Behring recently announced that Japan's Ministry of Health, Labour and ...
AbbVie, a research-based global biopharmaceutical company, has announced that the Japanese Ministry of Health, Labour an...
Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Hol...
